Recommendations of the European Stroke Initiative for management and treatment of stroke;Empfehlungen der Europäischen Schlaganfall-Initiative zur versorgung und behandlung des schlaganfalls

Nervenarzt

Volumn 72, Issue 10, 2001, Pages 807-819

  Hacke, W ^a   Kaste, M ^a   Olsen, T S ^a   Orgogozo, J M ^a   Bogousslavsky, J ^a  

^a Heidelberg ^*  (Switzerland)

Author keywords

Management; Stroke; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; DIPYRIDAMOLE; FIBRINOLYTIC AGENT; HEPARIN; TICLOPIDINE;

ARTICLE; BRAIN SCINTISCANNING; COMORBIDITY; CONSERVATIVE TREATMENT; DIAGNOSTIC APPROACH ROUTE; DISEASE COURSE; ELECTROENCEPHALOGRAPHY; HUMAN; NEUROSURGERY; PATIENT CARE; STROKE;

CEREBROVASCULAR ACCIDENT; DISEASE MANAGEMENT; EMERGENCY TREATMENT; EUROPE; FIBRINOLYTIC AGENTS; FLUID THERAPY; HUMANS; HYPOTHERMIA, INDUCED; INTENSIVE CARE; NEUROSURGICAL PROCEDURES; PRIMARY PREVENTION; REHABILITATION; THROMBOLYTIC THERAPY; THROMBOSIS;

EID: 0034757587     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001150170040     Document Type: Article

References (85)

1. Risk of stroke in male cigarette smokers
2. Stroke management in Europe
3. Guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council
4. Collaborative review of randomised trials of antiplatelet therapy. 1. Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients
5. Costs and gains in stroke prevention: European perspective
6. Benefit of endarterectomy in patients with symptomatic moderate or severe stenosis
7. Guidelines for carotid endarterectomy. A statement for healthcare professionals from a special writing group of the Stroke Council
8. Stroke, statins and cholesterol: A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors
9. Neurological acute stroke care: The role of European neurology
10. Thrombolytic therapy of acute basilar artery occulsion: Variables affecting recanalization and outcome
11. Intensive care for acute stroke in the community hospital setting
12. General therapy of acute ischemic stroke
13. Optimal oral anticoagulation therapy in patients with mechanical heart valves
14. A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
15. Radomized placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST Chinese Acute Stroke Trial
16. Timing for fever-related brain damage in acute ischemic stroke
17. Heparin in stroke with atrial fibrillation
18. Cigarette smoking and risk of stroke in middle-aged women
19. Blood pressure, stroke, and coronary heart disease. 2. Short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context
20. European stroke prevention study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke
21. Plasma atrial natriuretic factor and subarachnoid hemorrhage
22. A comparison of two doses of aspirin (30 mg vs 283 mg a day) in patients after a transient ischemic attack or a minor ischemic stroke
23. Behandlung des akuten ischämischen insults
24. European strategies for early intervention in stroke
25. Optimal oral anticoagulation therapy with nonrheumatic atrial fibrillation and recent cerebral ischemia
26. MRC European Carotid Surgery Trial: Interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis
27. Endarterectomy for asymptomatic carotid artery stenosis
28. Guidelines for the management of transient ischemic attacks
29. Cost of stroke
30. PROACT II: Recombinant prourokinase (r-ProUK) in acute cerebral thromboembolism. Initial Trial Results
31. Prevention of first stroke. A review of guidelines and a multidisciplinary consensus statement from the National Stroke Association
32. Recent infection as a risk factor for cerebrovascular ischemia
33. Elective intubation for neurologic deterioration after stroke
34. Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease
35. Critical care of acute ischemic stroke
36. Malignant middle cerebral artery territory infarction: Clinical course and prognostic signs
37. Randomised double-blind placebo-controlled trials of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)
38. Prevention of stroke in patients with nonvalvular atrial fibrillation: Views and reviews
39. Hypervolemic hemodilution treatment of acute stroke. Results of a randomized multicenter trial using pentastarch
40. Surgical treatment of cerebellar infarction
41. Effects of an ACE inhibitor, ramipril, on cardiovascular events in highrisk patients
42. Silent aspiration following stroke
43. Stroke unit treatment: Long-term effects
44. The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischaemic stroke
45. The cost of stroke to the National Health Service in Scotland
46. Haemodilution in acute stroke: Results of the Italian haemodilution trial
47. Heart type creatine kinase isoenzyme (CK MB) in acute cerebral disorders
48. Early Stroke Recognition: Developing an out-of-hospital NIH Stroke Scale
49. Acute stroke: Usefulness of early CT findings before thrombolytic therapy
50. Do stroke units safe lifes?
51. Antithrombotic therapy in atrial fibrillation
52. Exercise and risk of stroke in male physicians
53. A prospective study of aspirin use and primary prevention of cardiovascular disease in women
54. Thrombolytic therapy with streptokinase in acute ischaemic stroke
55. Tissue plasminogen activator for acute ischemic stroke
56. Effects of cerebrovascular lesions on the heart
57. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis
58. Pan European consensus meeting on stroke
59. Randomised trial of prophylactic daily aspirin in British male doctors
60. Reduction of stroke incidence after myocardial infarction with pravastatin: The cholesterol and recurrent events (CARE) study
61. Cholesterol, diastolic blood pressure and stroke. 13,000 strokes in 450,000 people in 45 prospective cohorts
62. Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus
63. Body temperature in acute stroke: Relation to stroke severity, infarct size, mortality and outcome
64. Therapeutic strategies in space-occupying cerebellar infarction based on clinical, neuroradiological and neurophysiological data
65. Decompressive surgery in space-occupying hemispheric infarction: Results of an open, prospective trial
66. Hypertension in patients with cerebrovascular accident: To treat or not to treat?
67. Stroke units versus general medical wards. I. Twelve and eighteen-month survival. A randomized, controlled trial
68. The protective effect of moderate alcohol consumption on ischemic stroke
69. Middle cerebral artery occlusion: Correlation of computed tomography and angiography with clinical outcome
70. Multicenter trial of hemodilution in acute ischemic stroke. 1. Results in the total patient population
71. Swedish aspirin low-dose trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events
72. Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction
73. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: Final results of the Systolic Hypertension in the Elderly Program (SHEP)
74. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
75. Defibrinogenation with Viprinex (ancrod) for the treatment of acute, ischemic stroke
76. Final report of the ongoing physicians health study
77. Prognosis of stroke patients requiring mechanical ventilation in a neurological critical care unit
78. Evaluation of long-term outcome and safety after hemodilution therapy in acute ischemic stroke
79. A systematic review of the randomised trials of organised impatient (stroke unit) care after stroke
80. Intravenous heparin for acute stroke. What can we learn from the megatrials?
81. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk complications in patients with type 2 diabetes (UKPDS 33)
82. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: Final results
83. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and Other Cerebrovascular Disorders
84. Angioplasty and stenting for restenosis after carotid endarterectomy, initial experience